Papillary Thyroid Carcinoma
📧 Sign up to get email alerts when something new happens for Papillary Thyroid Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Durvalumab Plus Tremelimumab for the Treatment of Patients With Progressive, Refractory Advanced Thyroid Carcinoma -The DUTHY Trial [Phase 2]
Phase 2 trial evaluating durvalumab plus tremelimumab in progressive, refractory advanced thyroid carcinoma (papillary and follicular subtyp…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers. [Phase 2, Phase 3]
The DETERMINE trial's Arm 07 is studying dabrafenib plus trametinib in patients with BRAF V600 mutation-positive cancers across age groups; …
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Deep Learning-Based Intraoperative Dual-tracer Video Analysis of Sentinel Lymph Node Mapping for Metastasis Prediction in cN0 Papillary Thyroid Carcinoma
This completed trial evaluates a deep learning–based intraoperative dual-tracer video analysis to predict sentinel lymph node metastasis in …
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: Molecular Analysis for Precision Surgery in Thyroid Cancer Trial [NA]
This update confirms completion of a trial evaluating molecular analysis to guide precision surgery in papillary thyroid carcinoma.
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors [Phase 1, Phase 2]
This phase 1/2 clinical trial update reports results for selpercatinib in pediatric participants with advanced solid tumors and primary CNS …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers. [Phase 2, Phase 3]
Phase 2/3 DETERMINE trial treatment arm 05 is evaluating the combination of vemurafenib and cobimetinib in adults with BRAF-positive cancers…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Robotic Surgery Via Bilateral Axillo-breast Approach for Relatively Low-risk Papillary Thyroid Carcinoma With Lateral Cervical Lymph Node Metastasis: a Safe and Effective Cosmetic Procedure in the Context of Prevalent Thyroid Ultrasound Screening
This completed trial evaluates a robotic bilateral axillo-breast approach for relatively low-risk papillary thyroid carcinoma with lateral c…
-
CLINICAL_TRIALS trial_result · 2025-11-13Clinical Trial Update: Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer [Phase 2]
Phase 2 clinical trial evaluating selpercatinib given before surgery for RET-altered thyroid cancers is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-10-31Clinical Trial Update: Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer [Phase 2]
Phase 2 trial update reports results from CaboNivoIpi (cabozantinib, nivolumab, ipilimumab) in advanced differentiated thyroid cancer, inclu…
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors [Phase 2]
Phase 2 monotherapy trial of tovorafenib (DAY101) in melanoma and other solid tumors was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: More Than 50% of Unifocal cN0 T1b/Small T2 Papillary Thyroid Carcinoma May Require Completion Thyroidectomy if Nodal Status is Evaluated
A completed clinical trial update suggests that more than half of patients with unifocal cN0 T1b or small T2 papillary thyroid carcinoma may…
-
CLINICAL_TRIALS trial_result · 2025-08-24Clinical Trial Update: Dabrafenib With or Without Trametinib in Treating Patients With Advanced Differentiated Thyroid Cancer [Phase 2]
Phase 2 trial evaluating dabrafenib with or without trametinib in advanced differentiated thyroid carcinoma, including follicular, papillary…
-
CLINICAL_TRIALS trial_result · 2025-08-05Clinical Trial Update: Microwave Ablation and Surgical Resection for Micropapillary Thyroid Carcinoma [NA]
The study evaluating microwave ablation in combination with surgical resection for papillary thyroid carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: Intraoperative Pathologic Evaluation of Central Lymph Nodes in Papillary Thyroid Carcinoma
A completed clinical trial from Seoul National University Hospital reports on intraoperative pathologic evaluation of central lymph nodes in…
-
CLINICAL_TRIALS trial_result · 2025-06-27Clinical Trial Update: A Study to Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer. [Phase 1]
A Phase 1 study intended to restore radioiodine sensitivity in advanced papillary thyroid carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 study results show activity and safety of pralsetinib in RET-altered cancers, including non-small cell lung cancer and thyroid can…
-
CLINICAL_TRIALS trial_result · 2025-05-20Clinical Trial Update: Treatment of Papillary Thyroid Carcinoma With Radiofrequency Ablation [NA]
A completed clinical trial evaluated radiofrequency ablation as a treatment for papillary thyroid carcinoma, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-05-11Clinical Trial Update: Active Surveillance for Low-risk Papillary Thyroid Carcinoma
The National Cancer Center Korea is conducting a clinical trial to evaluate active surveillance for low-risk papillary thyroid carcinoma, an…
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: Radiofrequency Ablation for the Treatment of Benign or Low Risk Thyroid Nodule [NA]
The clinical trial NCT05003856 evaluating radiofrequency ablation for benign or low-risk thyroid nodules was terminated; no results are prov…
-
CLINICAL_TRIALS trial_result · 2025-04-01Clinical Trial Update: Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Metastatic Radioactive Iodine Refractory Thyroid Cancer [Phase 1]
Phase 1 clinical trial evaluating Lutetium-177 DOTA-EB-FAPI in patients with metastatic, radioiodine-refractory thyroid cancer has completed…
-
CLINICAL_TRIALS trial_result · 2024-12-03Clinical Trial Update: Retro-Auricular Single-Site Endoscopic to Papillary Thyroid Carcinoma [NA]
A clinical trial evaluating a retro-auricular single-site endoscopic approach for papillary thyroid carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2024-12-03Clinical Trial Update: Safety of Endoscopic Thyroidectomy Via Retro-Auricular Single-Site Approach, Transoral Approach and Transareola [NA]
A completed clinical trial assessed the safety of endoscopic thyroidectomy using retro-auricular single-site, transoral, and transareolar ap…
-
CLINICAL_TRIALS trial_result · 2024-05-22Clinical Trial Update: Prediction of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma Based on Ultrasound and Cytological Images
A completed clinical trial evaluated predicting cervical lymph node metastasis in papillary thyroid carcinoma using ultrasound and cytologic…
-
CLINICAL_TRIALS trial_result · 2023-10-24Clinical Trial Update: Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC) [Phase 2]
A Phase 2 trial evaluating the combination of lenvatinib and pembrolizumab in differentiated thyroid cancers has completed, with results pos…
-
CLINICAL_TRIALS trial_result · 2022-12-28Clinical Trial Update: Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer [Phase 2]
Phase 2 trial evaluating trametinib for increasing tumoral iodine incorporation in patients with recurrent or metastatic thyroid cancer; res…